REQUEST A CONSULTATION

Ready to contact us for a consultation about your condition and our medical services? The staff of our Global Patient Services is ready to help. Please select the appropriate button to get started.
search-icon
News

Cancer Scientist at Sheba is Awarded Israel Prize for Medical Science

Prof. Gideon Rechavi, a world-renowned doctor, has been designated to receive the prestigious Israel Prize for Medical Science at a special ceremony to be held on April 20. He has committed his life’s work to researching the genetic aspects of various cancers, such as RNA sequencing. Prof. Rechavi published more than 330 articles in international scientific journals.

Prof. Rechavi, the recipient of Israel Prize, spearheads The Cancer Research Center at Sheba, which is involved in the latest, cutting-edge pre-clinical and clinical research projects. This facility’s work combines the most progressive diagnostic and treatment modalities to caring for cancer patients. Advanced technologies, such as gene sequencing, bioinformatics, microarrays, molecular cytogenetics, stem cells and more are implemented and constantly developed further.

“We are very proud of this achievement,” said Prof. Yitshak Kreiss, Director General of Sheba Medical Center. “Prof. Rechavi is well deserving of this prestigious award, working day and night to find novel ways to treat cancer.”

Sheba was recently ranked the #9 hospital in the world by Newsweek, and Prof. Rechavi’s distinction is an impressive addition to the medical center’s world-class achievements. Sheba is also making headlines for its state-of-the-art isolation and treatment units for the coronavirus epidemic.

Related
Sheba DUNS 100

For The Second Consecutive Year: Sheba Tops the Healthcare Sector on Dun & Bradstreet’s List of Leading Organizations

Dun & Bradstreet, the world’s foremost commercial data company, ranked 71 doctors from Sheba Medical Center in its list of the top Israeli clinical experts.…
Read More

Ayelet’s Miracle: The First Woman to Conceive Four Children Following Ovarian Tissue Cryopreservation

At 21, Ayelet Rozenberg was diagnosed with Hodgkin’s lymphoma. Facing aggressive therapies necessary to save her life, Ayelet feared she would never be able to…
Read More
bowel disease
News Sep 07.

Sheba Partners with Biomica to Advance Inflammatory Bowel Disease Care

As part of the new collaboration, Sheba and Biomica will engage in joint microbiome clinical research to develop better treatments for inflammatory bowel disease (IBD)…
Read More